(c) 2024 PillSync.com

Generic: naproxen is used for the treatment of Arthritis, Juvenile Arthritis, Rheumatoid Back Pain Bursitis Common Cold Dysmenorrhea Fever Gout Headache Inflammation Osteoarthritis Pain Pregnancy Trimester, Third Spondylitis, Ankylosing Toothache


IMPRINT: IP190 500     SHAPE: capsule
    COLOR: white

All Imprints

naproxen 500 mg - ip190 500 capsule white

naproxen 500 mg oral tablet - ip190 500 oval white

naproxen - naproxen 500 mg oral tablet - ip190 500 oval white

naproxen 375 mg - ip189 375 capsule white

naproxen 250 mg - ip188 250 round white

Boxed Warning

Boxed Warning Section

BOXED WARNING Cardiovascular Risk -NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. -Naproxen as Naproxen Tablets, USP is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery (see WARNINGS). Gastrointestinal Risk -NSAIDs may cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration. and perforation of the stomach or intestines, which can be fatal.


Go PRO for all pill images

Description Section


Each capsule contains:

Naxproxen, ESP ..........500 mg

Description Section


Dosage and Use: For dosage recommendations

and other important prescribing information, read accompanying insert.

Storage And Handling Section


Store at 20 to 25 C (68 to 77 F); excursions

permitted to 15 to 30 C (59 to 86 F)[See

USP Controlled Room Temperature]

Dispense in well-closed, light-resistant containers

as defined in the USP.  

Boxed Warning Section


BOXED WARNING

Cardiovascular Risk

-NSAIDs may cause an increased risk of serious cardiovascular thrombotic events,

myocardial infarction, and stroke, which can be fatal.

-Naproxen as Naproxen Tablets, USP is contraindicated for the treatment of peri-operative

pain in the setting of coronary artery bypass graft (CABG) surgery (see WARNINGS).

Gastrointestinal Risk

-NSAIDs may cause an increased risk of serious gastrointestinal adverse events including

bleeding, ulceration. and perforation of the stomach or intestines, which can be fatal.

Description Section


DESCRIPTION

Naproxen, USP is a proprionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory drugs.



Clinical Pharmacology Section


CLINICAL PHARMACOLOGY

Pharmacodynamics - Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and

antipyretic properties.

Clinical Studies Section


CLINICAL STUDIES

General Information - Naproxen has been studied in patients with rheumatoid arthritis, osteoarthritis,

juvenile arthritis, ankylosing spondylitis, tendonitis and bursitis, and acute gout.

Indications & Usage Section


INDICATIONS AND USAGE

Carefully consider the potential benefits and risks of naproxen tablets, USP and other treatments

before deciding to sue naproxen tablets, USP.

Contraindications Section


CONTRAINDICATIONS

Naproxen tablets, USP are contraindicated in patients with known hypersensitivity to naproxen, USP.

Warnings Section


WARNINGS

Cardiovascular Effects - Cardiovascular Thrombotic Events Clinical trials of several COX-2 selective

and non-selective NSAIDs of up to three years duration have shown an increased risk of serious cardiovascular (CV)

thrombotic events, myocardial infarction, and stroke, which can be fatal.

Precautions Section


PRECAUTIONS

General - Naproxen - containing products such as naproxen tablets, and other naproxen products should

not be used concomitantly since they all circulate in the plasma as the naproxin anion.



Adverse Reactions Section


ADVERSE REACTIONS

Adverse reactions reported in controlled clinical trials in 960 patients treated for rheumatoid arthritis

or osteoarthritis are uled below.

Overdosage Section


OVERDOSAGE

Symptoms and Signs   Significant naproxen overdosage may be characterized by lethargy, dizziness,

drowsiness, epigastric pain, abdominal discomfort, heartburn, indigestion, nausea, transient alterations in liver function,

hypoprothrombinemia, renal dysfunction, metabolic acidosis, apnea, disorientation or vomiting.

Dosage & Administration Section


DOSAGE AND ADMINISTRATION

Carefully consider the potential benefits and risks of naproxen tablets, USP and other treatment

options before deciding to use naproxen tablets, USP.

Patient Medication Information Section


MEDICATION GUIDE FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)

(See the end  of this Medication Guide for a ul of prescription NSAID medicines.)

Package Label.principal Display Panel




DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site